Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications-Reference-Cited by-同舟云学术

Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications

Published:2019-12-06 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Shan Jingxuan,Chouchane Aziz,Mokrab Younes,Saad Mohamad,Boujassoum Salha,Sayaman Rosalyn W.,Ziv Elad,Bouaouina Noureddine,Remadi Yasmine,Gabbouj Sallouha,Roelands Jessica,Ma Xiaojing,Bedognetti Davide,Chouchane Lotfi

Funder

Qatar National Research Fund

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference57 articles.

1. Breast cancer in Arab populations: molecular characteristics and disease management implications;Chouchane;Lancet Oncol.,2013

2. Cancer incidence in the Middle Eastern population of California, 1988–2004;Nasseri;Asian Pac J Cancer Prev.,2007

3. Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women;Hensley Alford;Breast Cancer Res Treat.,2009

4. Triple-negative breast cancer: immune modulation as the new treatment paradigm;Disis;Am Soc Clin Oncol Educ Book.,2015

5. Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis;Hendrickx;Oncoimmunology.,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between Single Nucleotide Polymorphisms from the Genes of Chemokines and the CXCR2 Chemokine Receptor and an Increased Risk of Endometrial Cancer;Cancers;2023-11-14

2. Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population;Gene;2023-10

3. Case Report: The Relationship of CCND1 RS614367 Polymorphism with Clinicopathological Features;Biomedical and Pharmacology Journal;2023-08-30

4. Vimentin‐positive invasive breast carcinoma of no special type: A breast carcinoma with lethal biological characteristics;Pathology International;2023-06-28

5. The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma;Journal of Clinical Medicine;2023-03-20